Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000034830Phase 4Not yet recruiting
Phase 4, randomised trial of ropivacaine in inguinal hernia and hydrocele (3 arms), sponsored by Department of Anesthesiology, Lanzhou University Second Hospital. Primary endpoint: Time to first postoperative use of rescue analgesic medication. Planned start Aug 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000034830.